Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Tuesday 05 February, 2019

Marinomed Biotech Ag

EANS-DD: Marinomed Biotech AG / Notification concerning transactions by persons performing managerial responsibilities pursuant to article 19 Market Abuse Regulation (MAR)

PR Newswire/euro adhoc/

EANS-DD: Marinomed Biotech AG / Notification concerning transactions by persons
performing managerial responsibilities pursuant to article 19 Market Abuse
Regulation (MAR)

--------------------------------------------------------------------------------
  Directors' Dealings-Announcement pursuant to artikle 19 MAR transmitted by
  euro adhoc with the aim of a Europe-wide distribution. The issuer is
  responsible for the content of this announcement.
--------------------------------------------------------------------------------


personal data:


responsible party:

name: Invest Unternehmensbeteiligungs Aktiengesellschaft Europaplatz 5a, 4020
Linz (legal person)

--------------------------------------------------------------------------------


reason:

reason: responsible party is a legal person associate to a person with
managerial responsibilities
name and surname: Dr. Gernot Hofer
function: Member of an administrative or supervisory board

--------------------------------------------------------------------------------


issuer information:

name: Marinomed Biotech AG
Legal Entity Identifier (LEI): 529900GN3B1EN80XF405

--------------------------------------------------------------------------------


information about deal:

ISIN: ATMARINOMED6
description of the financial instrument: Stock
type: acquisition
date: 01.02.2019; UTC+01:00
market: WIENER BOERSE AG, XWBO
currency: Euro


               price               volume
                  75                 6666

total volume: 6666
total price: 499950
average price: 75


--------------------------------------------------------------------------------




end of announcement                         euro adhoc
--------------------------------------------------------------------------------



issuer:       Marinomed Biotech AG
              Veterinärplatz 1
              A-1210 Wien
phone:        0043250774460
FAX:          0043250774493
mail:         [email protected]
WWW:          www.marinomed.com
ISIN:         ATMARINOMED6, AT0000A1WD52
indexes:      
stockmarkets: Wien
language:     English
                
The content and accuracy of news releases published on this site and/or 
distributed by PR Newswire or its partners are the sole responsibility of the 
originating company or organisation. Whilst every effort is made to ensure the 
accuracy of our services, such releases are not actively monitored or reviewed 
by PR Newswire or its partners and under no circumstances shall PR Newswire or 
its partners be liable for any loss or damage resulting from the use of such 
information. All information should be checked prior to publication.

a d v e r t i s e m e n t